APA

Cole K. E., Strick C. A., Paradis T. J., Ogborne K. T., Loetscher M., Gladue R. P., Lin W., Boyd J. G., Moser B., Wood D. E., Sahagan B. G. & Neote K. (19980707). Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. : The Journal of experimental medicine.

Chicago

Cole K E, Strick C A, Paradis T J, Ogborne K T, Loetscher M, Gladue R P, Lin W, Boyd J G, Moser B, Wood D E, Sahagan B G and Neote K. 19980707. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. : The Journal of experimental medicine.

Harvard

Cole K. E., Strick C. A., Paradis T. J., Ogborne K. T., Loetscher M., Gladue R. P., Lin W., Boyd J. G., Moser B., Wood D. E., Sahagan B. G. and Neote K. (19980707). Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. : The Journal of experimental medicine.

MLA

Cole K E, Strick C A, Paradis T J, Ogborne K T, Loetscher M, Gladue R P, Lin W, Boyd J G, Moser B, Wood D E, Sahagan B G and Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. : The Journal of experimental medicine. 19980707.